Board meets : Religare, Hikal
2009 March 25
Board meets: Religare Enterprises to reconsider terms of proposed rights issue (had approved rights issue of Rs 1802 cr @ 2:3 at Rs 355/sh in Sep 08).
Board meets: Hikal on merger of wholly owned subsidiary Hikal Pharma with itself
No related posts.